Health Catalyst (NASDAQ:HCAT) Announces Earnings Results

Health Catalyst (NASDAQ:HCAT) released its quarterly earnings results on Thursday. The company reported ($0.21) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.34) by $0.13, Briefing.com reports. The company had revenue of $36.80 million during the quarter, compared to analysts’ expectations of $36.44 million. The business’s revenue was up 60.1% on a year-over-year basis.

Health Catalyst stock opened at $41.05 on Friday. Health Catalyst has a 52 week low of $36.29 and a 52 week high of $49.85.

Several equities analysts have recently commented on HCAT shares. JPMorgan Chase & Co. started coverage on Health Catalyst in a research note on Monday. They set an “overweight” rating and a $50.00 target price for the company. Piper Jaffray Companies started coverage on Health Catalyst in a research note on Monday. They set an “overweight” rating and a $47.00 target price for the company. Evercore ISI started coverage on Health Catalyst in a research note on Monday. They set an “outperform” rating and a $50.00 target price for the company. Goldman Sachs Group started coverage on Health Catalyst in a research note on Monday. They set a “buy” rating and a $49.00 target price for the company. Finally, SunTrust Banks started coverage on Health Catalyst in a research note on Monday. They set a “buy” rating and a $53.00 target price for the company. Eight analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and an average target price of $51.29.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services.

Further Reading: Retained Earnings

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.